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Abstract 
Background: There is growing evidence of the negative impact of alcohol on morbidity and mortality of individuals 
living with HIV but limited evidence of in utero effects of HIV and alcohol on exposure on infants.
Methods: We conducted a population-based birth cohort study (N = 667 mother-infant dyads) in South Africa 
to investigate whether maternal alcohol use and HIV affected gestational outcomes. Descriptive data analysis was 
conducted for all variables using frequency distributions, measures of central tendency, and estimates of variance. 
Hierarchical multiple regression was conducted to determine whether maternal alcohol use, maternal HIV status and 
other risk factors (socioeconomic status, smoking, depression) predicted infant outcomes.
Results: Our results showed severity of recent alcohol use and lifetime alcohol use predicted low birth weight. Simi-
larly lifetime alcohol use predicted shorter infant length, smaller head length, smaller head circumference, and early 
gestational age. However, HIV status was not a significant predictor of gestational outcomes.
Conclusions: The unexpected finding that maternal HIV status did not predict any of the gestational outcomes may 
be due to high rates of ART usage among HIV-infected mothers. The potentially negative effects of HIV on gestational 
outcomes may have been attenuated by improved maternal health due to high coverage of antiretroviral treatment 
in South Africa. Interventions are needed to reduce alcohol consumption among pregnant mothers and to support 
healthy growth and psychosocial development of infants.
Keywords: Gestational outcomes, Alcohol, HIV, South Africa, Pregnancy
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Alcohol use, including hazardous and harmful levels, 
remains a serious health problem among individuals liv-
ing with HIV globally and in South Africa specifically. 
In South Africa, the country with the largest number 
of people living with HIV (PLWH) globally [1], alcohol 
consumption is among the highest in the world [2]. A 
national survey documented that 9% of the population 
engage in risky or hazardous drinking [3–5]. Even more 
concerning is a high proportion of individuals living 
with HIV struggle with alcohol abuse and dependence. 
While national estimates are unavailable, local studies in 
communities with high prevalence of HIV show rates of 
recent alcohol use as high as 51% as well as concerning 
levels of dependence or abuse among PLWH (7%) [6, 7].
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A growing body of literature highlights the synergis-
tic and detrimental effects of alcohol on morbidity and 
mortality of individuals living with HIV [8]. Alcohol 
use accelerates disease progression via biological path-
ways. This includes both increased viral replication and 
diminished immune function. For example, alcohol use 
is associated with depletion of CD4 cells [9, 10] and has 
been shown to negatively affect performance of T and 
B lymphocytes and other important immune responses 
[11–15]. Alcohol use also accelerates disease progression 
via behavioral pathways for PLWH. A recent meta-analy-
sis and a systematic review showed that alcohol use was 
linked to poorer adherence to antiretroviral therapy and 
lower utilization of health services [16, 17].
The negative health-related consequences of alcohol 
use among PLWH may be of even greater concern among 
pregnant women living with HIV. Several meta-analyses 
indicate that heavy alcohol use during pregnancy can 
increase risk for low birth weight, preterm birth, small 
gestational age [18] and long term growth impact includ-
ing gross motor deficits [19]. Similarly, maternal HIV 
infection has been associated with poor fetal outcomes 
including low birth weight [20] and pre-term delivery 
[21, 22]. Maternal HIV infection, particularly mother-to-
child transmission of HIV, can affect fetal development 
of the infant brain. For example, there is growing evi-
dence that babies infected with HIV are at risk of signifi-
cantly poorer performance of infant motor and cognitive 
development even if they do not meet criteria for HIV 
encephalopathy [23]. There may be synergistic effects of 
alcohol and HIV on health, particularly during the ges-
tational period. As such, additional research is needed to 
determine whether HIV might interact with alcohol to 
negatively affect infant outcomes among babies born to 
mothers affected by HIV and using alcohol.
South Africa is an ideal setting to investigate whether 
living with HIV and using alcohol during pregnancy 
might have synergistic affects upon fetal outcomes. Rates 
of alcohol use during pregnancy have been well-docu-
mented in South Africa. South Africa has the highest 
global rates of fetal alcohol syndrome (FAS) [24]. How-
ever, only a handful of studies document rates of alco-
hol use among HIV-infected pregnant women in South 
Africa. One cross-sectional survey of pregnant women 
attending clinics documented that 18 percent engaged 
in drinking during pregnancy and 67% reported prob-
lem drinking (more than 3 drinks in one sitting) [25]. 
Another study analyzing a subset of data from a longi-
tudinal cohort of female drinkers in Cape Town docu-
mented that 73% continued drinking after recognition of 
pregnancy [26]. However, no study to date has compared 
alcohol use patterns among HIV-positive and HIV-neg-
ative pregnant women or examined whether alcohol use 
among pregnant mothers living with HIV has any effect 
on gestational outcomes.
We conducted a population-based birth cohort study 
in the Western Cape Province, a region supported heav-
ily by an agricultural economy centered on wine produc-
tion. Our choice of this site was purposeful given the 
rates of alcohol abuse and dependence, and HIV preva-
lence in this region. Rates of alcohol use may be particu-
larly problematic due to the historical legacy of the ‘dop’ 
system where farm workers were paid in crude wine [27]. 
Rates of FAS or Partial Fetal Alcohol Syndrome (PFAS) 
are alarmingly high, at 135–207 cases per 1000 people in 
certain high risk communities in the Western Cape [28]. 
Our analyses focused on determining whether there were 
differences in alcohol intake between HIV-positive and 
HIV-negative pregnant women and whether HIV or alco-
hol had any synergistic effects of gestational outcomes of 
birth weight percentile, length, head circumference, and 
gestational age.
Methods
Data was collected from an investigation of child health, 
called the Drakenstein Child Health Study (DCHS). The 
DCHS consisted of a multidisciplinary birth cohort study 
following mother–child dyads from the prenatal period 
through to five years of age [29, 30]. The aim of DCHS is 
to investigate the epidemiology, etiology, and risk factors 
of childhood respiratory disease and the determinants of 
child health in a low socioeconomic area of South Africa 
[30]. The study investigates the role and interaction of 
possible risk factors in 7 areas (environmental, infectious, 
nutritional, genetic, psychosocial, maternal and immuno-
logical risk factors) that may impact child health.
Design
Pregnant women were recruited from two primary care 
clinics in the Drakenstein sub-district near Cape Town, 
South Africa between March 2012 and September 2014. 
Data collection occurred at these two clinics (maternal 
data) and at a central hospital (newborn outcomes). Par-
ticipants were enrolled in the study at 20–28 weeks gesta-
tion upon presenting for antenatal booking. The mothers 
were followed throughout pregnancy and mother–child 
dyads are followed until five years after birth. Data col-
lection for the DCHS remains ongoing. Throughout the 
study, participants receive regular medical care as per the 
South Africa national program and expanded program 
for immunization (EPI) schedule.
Setting
The DCHS is located in the Drakenstein area, a peri-
urban area, 60 km outside Cape Town, South Africa with 
a population of approximately 200,000. The community 
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is stable, with low levels of immigration or emigration. 
The local economy is based around commercial agricul-
ture and light industry. More than 90% of the population 
access health care in the public sector including antena-
tal and child health services [31]. This area has a well-
established, free primary health care system, with high 
coverage for childhood immunizations. The public health 
system is comprised of 23 primary health care clinics and 
one centralized hospital where all births and all hospital-
based pediatric care, including admissions occur [30].
Participants
To be eligible for the study, participants were: (a) over 
age 18, (b) pregnant, (c) 20–28 weeks gestation, and (d) 
receiving antenatal care at a participating study site. 
The two primary clinics were TC Newman clinic (serv-
ing a predominantly “Coloured” or mixed ancestry com-
munity) and Mbekweni clinic (serving a predominantly 
black African community). Exclusion criteria were mini-
mal in order to maximize generalizability, and focused 
primarily on those individuals who did not live in the 
region (and could not readily complete follow-up assess-
ments) or those who were intending to move out of the 
district within the following 2  years. The cohort com-
prised mothers presenting in an unfiltered manner to 
the antenatal services and were not selected for any clini-
cal risk factors or exposures. The study was approved by 
the Faculty of Health Sciences, Human Research Ethics 
Committee, University of Cape Town (401/2009), and by 
the Western Cape Provincial Health Research committee. 
Written informed parental consent was obtained from all 
participants at the time of enrolment.
Measures
Demographics
Demographic data was collected regarding participant 
age, education, employment, and socioeconomic sta-
tus (SES). For our purposes, a composite SES score was 
developed in order to categorize participants into quar-
tiles based on their relative SES. This composite score 
is calculated based on current employment status and 
standardized scores of educational attainment, household 
income, and a composite asset index based on access to 
household resources, amenities, and market access. Par-
ticipants were categorized as being of low, low-moderate, 
moderate-high, or high SES based on their relative com-
posite SES score.
HIV status
Maternal HIV status was determined using an HIV 
ELISA test, which all mothers in South Africa receive 
during pregnancy due to the high prevalence of HIV. 
Those who tested positive for HIV self-reported whether 
she was prescribed antiretroviral therapy. Mothers who 
were newly diagnosed received a second confirmatory 
HIV ELISA test and were referred for counseling and 
evaluation for treatment initiation as per standard man-
agement guidelines.
Newborn birth outcomes
All babies were born at a central hospital that serves 
the communities of both clinics. Trained clinical staff 
recorded newborn birth weight (kilograms) at the time 
of delivery, using a digital scale with a precision level 
of 10  g. Gestational age (weeks), head circumference 
and length in centimeters were also recorded at birth. 
We defined low birth weight and very low birth weight 
according to World Health Organization’s (WHO’s) 
parameters for weight for age, with low birth weight 
defined as less than 2.5 kilograms and very low birth 
weight as less than 1.5 kg [32]. Percentile for infant birth 
weight was then calculated using the formula proposed 
by Mikolajcyzk et al. [33]. This formula enabled us to cal-
culate the birth weight percentile based on gestational 
week of each infant. We used full-term, low-risk infants 
(N = 100) as the reference group for anchoring our per-
centile estimates. This method for estimating fetal weight 
percentiles has a better ability to predict adverse perina-
tal outcomes than other unadjusted and fully individual-
ized formulas [33].
Alcohol use
Risk of substance use was assessed using the alcohol, 
smoking and substance involvement screening test 
(ASSIST) at the second antenatal visit (28–32 weeks ges-
tation). This tool was developed by the WHO to detect 
psychoactive substance use and related disorders in pri-
mary care settings. It has shown good reliability, fea-
sibility and validity in international, multisite studies 
[34, 35], and is useful for identifying risk of substance 
dependence in poly-substance abusers with varying 
degrees of psychopathology. Seven items are included 
to assess alcohol and other drug use across 10 categories 
(i.e., tobacco products; alcoholic beverages; cannabis; 
cocaine; amphetamine-type stimulants; inhalants, seda-
tives or sleeping pills; hallucinogens; opioids; and a gen-
eral category entitled “other”, in which the participant is 
required to specify the substance used). ASSIST scores 
from 0 to 10 for alcohol and 0–3 for illicit drugs indicat-
ing low-risk, scores from 11 to 26 for alcohol and 4–26 
for illicit drugs indicate moderate-risk and scores above 
26 indicate high risk of severe problems, with the likeli-
hood of substance dependence. The higher the score, the 
greater substance-related risk. The ASSIST has good reli-
ability scores and has been validated in numerous popu-
lations [36], as well as primary care settings [37]. For our 
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purposes, only data for alcohol were extracted from the 
ASSIST, as reports of other substance use were negligi-
ble with the exception of tobacco where a biochemical 
measure of exposure was used as detailed below. Life-
time alcohol use was a dichotomous variable coded as 0, 
1. Past 3 month alcohol use severity was calculated as a 
continuous variable using standard scoring techniques to 
calculate a sum score based on past 3-month alcohol use 
frequency, craving, consequences, and other symptoms 
of alcohol use disorders as detailed above [38].
Tobacco use
Biochemical verification of smoking status was deter-
mined through cotinine urine analysis collected on the 
same day as the baseline interview. Cotinine is a nicotine 
metabolite that is measurable among people who smoke, 
use smokeless tobacco, use nicotine products, or are 
exposed to environmental tobacco smoke. An antenatal 
urine cotinine cut-off value of 500 was used to distin-
guish active smokers from non-smokers [39].
Depression
The Beck Depression Inventory-II (BDI-II) [40] was used 
to assess depressive symptomatology. This is a widely 
used self-report measure of the severity of depressive 
symptoms with strong internal consistency and concur-
rent validity in clinical and non-clinical samples [41, 42]. 
Each item is assessed on a severity scale ranging from 0, 
“absence of symptoms”, to 3 “severe, often with functional 
impairment”. A total score was obtained by summing 
individual item responses, with higher scores indicative 
of more severe depressive symptoms.
Data analysis
Descriptive data analysis was conducted for all variables 
using frequency distributions, measures of central ten-
dency, and estimates of variance. Hierarchical multiple 
regression was conducted to determine whether mater-
nal HIV status, alcohol use, and other risk factors (socio-
economic status or SES, smoking, depression) predicted 
infant outcomes. Infant outcomes included birth weight 
percentile, length, head circumference, and gestational 
age. All outcomes were entered as continuous variables 
in regression analyses. The analyses were conducted in 
a step-wise fashion to examine the unique contributions 
for each block of predictor variables. The four steps/
blocks of variables in the regression analyses included 
(in order): (1) HIV status, (2) SES score, BDI-II score, 
and smoking status, (3) alcohol use, and (4) interaction 
variables (HIV by alcohol use and HIV by smoking sta-
tus). We examined separate models using the predictors 
past 3-month alcohol use severity and lifetime alcohol. 
All regression models were examined for violations of 
normality, linearity, homoscedasticity, redundancy, and 
multicollinearity. Data performed excellently on all crite-
ria except for length of gestation. Length of gestation was 
non-normal (skew = −2.04, kurtosis = 7.38) and the log 
of this variable was used in the analysis. Statistical signifi-
cance was set at the 0.05 level.
Results
Descriptive analyses
The sample included 667 mother-infant dyads of whom 
19.6% (n = 131) of the maternal sample was HIV-positive 
(Table 1). All mothers with HIV were on ART; no infants 
were HIV-infected. A diverse range of socioeconomic 
backgrounds was represented, and 26.7% (n  =  178) 
of mothers were categorized as low SES. In terms of 
depression as measured by the BDI-II, 25% (n = 167) of 
the mothers reported symptoms consistent with mild 
depression, 22.5% (n =  150) reported moderate depres-
sion, and 7.8% (n = 52) reported high/severe depression. 
With regards to alcohol use as measured by the ASSIST, 
42.2% (n =  280) of mothers reported a lifetime history 
of alcohol use, and 21.54%, (n =  148) reported alcohol 
use in the past 3-months. Heavy alcohol use in the past 
3-months was reported by a small percentage of moth-
ers (3.1%; n = 21), moderate alcohol use was reported by 
7.7% (n =  53), and light use by 10.8% (n =  74). In this 
cohort, HIV-infected mothers had significantly lower 
lifetime history of alcohol use (14.6%) compared to 
HIV-negative mothers (48.9%), χ2 (1, N = 664) = 50.32, 
p < 001; lower 3-month alcohol use (light use: 12.8% vs. 
10.8%, moderate use: 8.5% vs. 4.6%, heavy use: 2.9% vs. 
3.8%, χ2 (1, N = 148) = 7.78, p < 0.020. Approximately 1 
in 3 mothers were current smokers (32.7%; n = 213).
Infant outcomes are presented in Table  2. The mean 
birth weight was 3.02 kilograms (SD =  0.58), with 3.3% 
(n = 22) of infants categorized as low birth weight (<10th 
percentile) and 4.8% (n =  32) of infants categorized as 
very low birth weight (<3rd percentile). The mean gesta-
tional age was 38.35 weeks (SD = 2.58). Pre-term infants 
(<37 weeks gestation) accounted for 15.6% (n = 104) of 
the infant sample. The mean head circumference was 
33.55  cm (SD =  1.87). The mean length was 49.86  cm 
(SD = 3.8).
Hierarchical multiple regression analyses
Birth weight percentile
Model results for the hierarchical multiple regres-
sion analysis for birth weight percentile is presented in 
Table  3. Step 1 of the model, which included HIV sta-
tus was not significant, and accounted for a very small 
proportion of variance in birth weight percentile, F (1, 
648) =  2.92, p =  0.09, R2 =  0.004. Step 2, which added 
smoking, SES, and depression, was significant, F (4, 
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648) = 10.88, p < 0.001, R2 = 0.06, and increased the pro-
portion of variance accounted for by 6% (ΔR2 =  0.06). 
Step 3, which added alcohol use severity was significant, 
F (5, 650) =  10.17, p  <  0.001, R2 = 0.07. The change in 
variance accounted for was 1% (ΔR2  =  0.01). Step 4, 
which added the interaction terms, HIV by alcohol and 
HIV by smoking, did not improve the model. Therefore 
Step 3 was chosen as the final model. The standardized 
beta weights for the final model are presented in Table 4. 
Alcohol use severity (β = −0.10), smoking (β = −0.18), 
and depression (β = −0.09) were significant predictors of 
birth weight percentile.
We ran a subsequent model using lifetime alcohol use 
as a predictor in Step 3 of the regression equation. Step 
Table 1 Maternal characteristics and risk factors by maternal HIV status
HIV negative HIV positive Total p value
N = 556 % N = 131 % N = 667 %
Socio-economic status <0.000
 Low 125 23.32 53 40.46 178 26.69
 Low-moderate 101 18.84 34 25.95 135 20.24
 Moderate-high 157 29.29 27 20.61 184 27.59
 High 153 28.54 17 12.98 170 25.49
Depression <0.095
 Minimal 244 45.52 54 41.22 298 44.68
 Mild 137 25.56 30 22.90 167 25.04
 Moderate 120 22.39 30 22.90 150 22.49
 High 35 6.53 17 12.98 52 7.80
Lifetime alcohol use
 Yes 261 48.88 19 14.62 280 42.17 <0.000
Past 3-month alcohol use severity score <0.020
 None 422 75.90 117 89.31 539 78.46
 Light 71 12.77 3 2.29 74 10.77
 Moderate 47 8.45 6 4.58 53 7.71
 Heavy 16 2.88 5 3.82 21 3.06
Smoking (Cotinine)
 Yes 183 35.06 30 23.08 213 32.67 <0.009
Table 2 Infant characteristics by maternal HIV status
cm centimeters, kg kilograms
HIV negative HIV positive Total p value
N (556) % N (131) % N (667) %
Birth weight percentile (%) <0.748
 <3 28 5.23 4 3.05 32 4.80
 3 to <10 20 3.74 2 1.53 22 3.30
 ≥10 487 91.03 125 95.42 612 91.89
Gestational age (full/pre-term)
 <37 weeks 80 14.93 24 18.32 104 15.59 <0.337
HIV negative HIV positive Total p value
Mean SD Mean SD Mean SD
Infant birth weight (kg) 3.01 0.58 3.03 0.58 3.02 0.58 <0.729
Infant head circumference (cm) 33.50 1.80 33.76 2.08 33.55 1.87 <0.944
Infant length (cm) 49.87 3.63 49.84 4.48 49.86 3.8 <0.153
Length of gestation (weeks) 38.39 2.45 38.21 3.07 38.35 2.58 <0.489
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1 and Step 2 model results were identical. Step 3, which 
added lifetime alcohol use was also significant, F (5, 
648) =  11.91, p  <  0.001, R2 =  0.085, and increased the 
proportion of variance accounted for by 2% (ΔR2 = 0.02). 
The standardized beta weight for lifetime alcohol use was 
−0.161 (p < 0.001). In Step 4, the interaction terms were 
not significant predictors of birth weight percentile.
Infant length
Model results for the hierarchical multiple regression 
analysis for infant length are presented in Table 3. Step 1 
of the model, which included HIV status only was not sig-
nificant, and accounted for no variance in infant length, 
F(1, 647) =  0.001, p =  0.99, R2  <  0.000. Step 2, which 
added smoking, SES, and depression, was significant F 
(4, 647) = 8.23, p < 0.001, R2 = 0.05, and increased the 
proportion of variance accounted for by 5% (ΔR2 = 0.05). 
Step 3 and Step 4 did not improve the model. Smoking 
(β = −0.196) was the only significant predictor of infant 
length.
We ran a subsequent model using lifetime alcohol use 
as a predictor in Step 3 of the regression equation. Step 
1 and Step 2 model results were identical. Step 3, which 
added lifetime alcohol use was also significant, F (5, 
645) = 7.14, p < 0.001, R2 = 0.053, and increased the pro-
portion of variance accounted for by 0.4% (ΔR2 = 0.004). 
The standardized beta weight for lifetime alcohol use was 
−0.07 (p =  0.09). In Step 4, the interaction terms were 
not significant predictors of infant length.
Head circumference
Model results for the hierarchical multiple regres-
sion analysis for head circumference are presented in 
Table  3. Step 1 of the model, which included HIV sta-
tus only was not significant, and accounted for very lit-
tle variance in head circumference, F (1, 645)  =  2.10, 
p  =  0.148, R2  =  0.003. Step 2, which added smoking, 
SES, and depression, was significant F (4, 645) =  11.73, 
p  <  0.001, R2  =  0.07, and increased the proportion of 
variance accounted for by 7% (ΔR2 =  0.07). Step 3 and 
Table 3 Results of multiple regression analyses for birth weight percentile, length, head circumference, and gestational 
age
df Mean square F value p value R2 Ä R2
Birth weight percentile
 Block 1 HIV status (pos/neg) 1 3004 2.92 0.088 0.00
 Block 2 Smoking, depression, SES 4 10,597 10.88 0.000 0.06 0.06
 Block 3 3-month alcohol use severity 5 9816 10.17 0.000 0.07 0.01
 Block 4 Interactions 7 7058 7.29 0.000 0.07 0.00
Length
 Block 1 HIV status (pos/neg) 1 0.001 0.001 0.992 0.00
 Block 2 Smoking, depression, SES 4 115.17 8.23 0.000 0.05 0.05
 Block 3 3-month alcohol use severity 5 93.36 6.67 0.000 0.05 0.00
 Block 4 Interactions 7 66.83 4.76 0.000 0.05 0.00
Head circumference
 Block 1 HIV status (pos/neg) 1 7.352 2.10 0.148 0.00 0.00
 Block 2 3-month alcohol use severity 4 38.649 11.73 0.000 0.07 0.07
 Block 3 3-month alcohol use severity 5 31.496 9.56 0.000 0.07 0.00
 Block 4 Interactions 7 22.599 6.84 0.000 0.07 0.00
Gestational age (log)
 Block 1 HIV status (pos/neg) 1 0.003 0.60 0.439 0.00
 Block 2 Smoking, depression, SES 4 0.021 3.86 0.004 0.02 0.02
 Block 3 3-month alcohol use severity 5 0.021 3.85 0.002 0.03 0.01
 Block 4 Interactions 7 0.015 2.80 0.007 0.03 0.00
Table 4 Standardized beta weights and  t test results 
for predictors of birth weight percentile
SES socioeconomic status, BDI Beck Depression Inventory
Beta SE t p value
Birth weight percentile
 Constant 2.34 24.39 <0.000
 Mother’s confirmed HIV status 0.057 3.14 1.47 0.143
 SES 0.046 0.59 1.16 0.247
 BDI score −0.085 0.13 −2.18 0.030
 Smoker (yes, no) −0.184 2.68 −4.71 <0.000
 3-month alcohol use severity −0.103 0.17 −2.63 0.009
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Step 4 did not improve the model. Smoking (β = −0.21), 
and depression (β = −0.09) were significant predictors of 
head circumference.
We ran a subsequent model using lifetime alco-
hol use as a predictor in Step 3 of the regression equa-
tion. Step 1 and Step 2 model results were identical. 
Step 3, which added lifetime alcohol use was also sig-
nificant, F (5, 645) =  10.35, p  <  0.001, R2 =  0.068, and 
increased the proportion of variance accounted for by 
0.5% (ΔR2  =  0.005). The standardized beta weight for 
lifetime alcohol use was −0.08 (p = 0.06). In Step 4, the 
interaction terms were not significant predictors of head 
circumference.
Gestational age
Model results for the hierarchical multiple regression 
analysis for gestational age are presented in Table 3. Step 
1 of the model, which included HIV status was not signif-
icant, and accounted for very little variance in gestational 
age, F (1, 651) = 0.60, p = 0.44, R2 = 0.001. Step 2, which 
added smoking, SES, and depression, was significant F 
(4, 651) = 3.86, p = 0.023, R2 = 0.02, and improved the 
model, (ΔR2 = 0.02). Step 3 and Step 4 did not improve 
the model. Only SES was significantly related to gesta-
tional age (β = 0.14).
We ran a subsequent model using lifetime alcohol use 
as a predictor in Step 3 of the regression equation. Step 
1 and Step 2 model results were identical. Step 3, which 
added lifetime alcohol use was also significant, F (5, 
648) =  11.91, p  <  0.001, R2 =  0.085, and increased the 
proportion of variance accounted for by 2% (ΔR2 = 0.02). 
The standardized beta weight for lifetime alcohol use was 
−0.161 (p < 0.001). In Step 4, the interaction terms were 
not significant predictors of birth weight percentile.
Discussion
This is the first study that examines the relationship 
between maternal HIV and alcohol use on infant birth 
outcomes in a setting with some of the highest global 
prevalence of HIV and alcohol use. Our results indicate 
that there were concerning levels of lifetime and recent 
alcohol use among pregnant women. In regards to alco-
hol use, we found lower lifetime and recent alcohol use 
reported by HIV-positive mothers. Recent and life-
time alcohol use predicted lower birth weight, and life-
time alcohol use predicted shorter infant length, smaller 
head circumference, and younger gestational age. The 
finding that alcohol use severity did not predict all ges-
tational outcomes was unexpected, and is possibly due 
to relatively low rates of reported past 3-month alcohol 
use overall, and large percentages of light alcohol users 
among past 3-month alcohol users. The small number of 
heavy alcohol users documented on this self-report tool 
likely limited our ability to detect alcohol use on gesta-
tional outcomes. Regardless, the overall findings point 
towards the detrimental effects of alcohol on infant out-
comes. The negative effects of alcohol on gestational out-
comes borne out in our cohort are consistent with the 
existing literature [18].
We also examined whether maternal HIV and alcohol 
had any synergistic effects of gestational outcomes. Our 
results for this analyses showed that HIV and alcohol did 
not appear to have significant synergistic effects on ges-
tational outcomes of birth weight percentile, length, head 
circumference, and gestational age. These findings were 
surprising, but should be interpreted with caution. Pos-
sible explanations for these unexpected findings might 
include that the limited number of heavy alcohol users in 
the sample as mentioned previously, or benefits of peri-
natal mother to child transmission (PMTCT) programs 
may be attenuating the synergistic effects of alcohol 
and HIV on gestational outcomes among HIV-infected 
mothers, nearly all who were on antiretroviral treat-
ment. South Africa has successful PMTCT programs 
which have provided substantial HIV prevention benefits 
to both mothers and babies in South Africa. There may 
still be a synergistic negative effect of HIV and alcohol on 
the long-term developmental outcomes of children but 
this needs further investigation with larger samples of 
mothers with diverse adherence behaviours as well pos-
sible purposeful sampling of mothers using alcohol on 
the more moderate to severe end of the spectrum. Such 
type of future sampling would allow further exploration 
of the relationship between HIV status, varying ART 
adherence, and alcohol on gestational outcomes. Studies 
from elsewhere in Southern Africa indicate that antiret-
roviral treatment (ART) given to prevent mother-to-child 
transmission attenuates the negative effects of maternal 
HIV on fetal outcomes. For example, recent retrospec-
tive cohort data from a study in Malawi showed that 
HIV-infected children had significantly poorer health 
outcomes (development and functioning) than their 
uninfected peers [43].
Limitations
We recognize several study limitations that offer several 
areas for development in future studies. First, this study 
uses self-report for alcohol data. Social reporting bias 
may be an issue especially for recent alcohol use. This 
may be due in part, to low literacy which necessitated 
field-worker administered assessments. Although field-
workers were trained carefully in sensitive interviewing 
techniques, future studies could be aided by audio com-
puter assisted self-interviewing (A-CASI) techniques 
which has been shown to improve accuracy of reporting 
on sensitive behaviors including substance use [44, 45]. 
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Improved methods for gathering substance use may also 
address possible issues of under-reporting due to social 
desirability bias so the use of audio computer assisted 
self-interviewing methods or bio-verifiable methods for 
use may be warranted. Future studies could also be aided 
by the use of biomarker verification of alcohol [46]. Self-
report on other drugs use are extremely low in this com-
munity. While alcohol has relative social acceptability, 
mothers, particularly in the context of pregnancy remain 
reluctant to volunteer this information. Second, longitu-
dinal data would have enhanced our ability to assess the 
temporal relationship between maternal HIV and alco-
hol use. Findings indicated that mother’s HIV infection 
did not seem to adversely affect intra-uterine growth in 
regards to weight, length, head circumference, and ges-
tational age. Future longitudinal studies could further 
develop our understanding of the role alcohol plays in 
risk of HIV infection among women desiring safe con-
ception. Additional research should further explore why 
and how HIV infection might be linked to alcohol sever-
ity scores, and how differential alcohol use might impact 
ART adherence. The concerning levels of recent alcohol 
among HIV-infected mothers also suggests that future 
studies need to explore the temporal association between 
HIV, alcohol, and psychosocial outcomes among HIV-
infected mothers, especially in relation to gestational out-
comes. A particularly important focus of future studies 
is a better understanding of long-term growth outcomes 
among children born to HIV-infected mothers who are 
drinking at more severe levels. Even if children are not 
infected, or do not demonstrate poor gestational out-
comes, there may be long-term developmental, growth, 
and psychosocial implications of maternal alcohol use 
among HIV-infected mothers. Despite these limitations 
which highlight areas to develop for future research, 
there are several strengths to this study. These include a 
population-based sample, use of dyadic data, and explo-
ration of the effect of maternal HIV and alcohol use on 
gestational outcomes among a high risk population.
Summary and conclusions
Although the broader literature suggests that HIV and 
alcohol have detrimental synergistic effects on the mor-
tality and morbidity of individuals living with HIV, find-
ings from this study indicate that HIV exposure alone in 
this cohort does not confer risk of poor growth outcomes 
at birth. The effect of maternal HIV and alcohol use on 
gestational may be attenuated by ARTs with similar find-
ings from several recent meta-analyses and systematic 
reviews showing good maternal and infant outcomes 
for HIV-infected mothers on ARTs [47, 48]. While such 
findings are positive, they do not negate the poten-
tially harmful effects of HIV and alcohol on long-term 
developmental outcomes of children, which need to be 
explored further. Our study highlights the importance 
of South Africa’s robust program of PMTCT of HIV. 
PMTCT is critical for supporting healthy mothers and 
protecting infants during the gestational period. How-
ever, mothers and their infants from high risk communi-
ties remain vulnerable to contextual factors which may 
impact individually and synergistically on gestational and 
developmental outcomes and meeting the needs of fami-
lies is likely to require a broad approach.
While continued investment in PMTCT has pro-
vided immense benefits for mothers and children, and 
prevented adverse effects of HIV on mothers and their 
infants, additional investment is needed to develop inter-
ventions and provide policy and programmatic support 
to address the complex challenges faced by HIV-infected 
mothers including alcohol and nicotine use, poor men-
tal health, and low SES. Indeed, our study highlights that 
these families face multiple risks that necessitate a stra-
tegic and intensive family approach that links together 
complementary intervention approaches to create what 
experts have termed, “a universal lattice of protec-
tion” [49]. At the foundation of these approaches is the 
understanding of HIV as a family disease that takes place 
against the complicated backdrop of overlapping epidem-
ics of substance use, poor mental health, and poverty. 
Intervening at critical time points in the family trajectory, 
such as during gestation and early birth, offer impor-
tant opportunities for prevention and building family 
resilience.
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